The role of microparticles in chronic obstructive pulmonary disease

Toru Takahashi1, Hiroshi Kubo2

  • 1Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine, Sendai, Japan ; Cellular and molecular lung biology research units, Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, Canada ; Department of Anesthesiology, Tohoku University Hospital, Sendai, Japan.

Insights

Endothelial microparticles (EMPs) indicate cell injury in chronic obstructive pulmonary disease (COPD). Elevated EMPs correlate with lung destruction and airflow limitation, suggesting their role as biomarkers for COPD progression.

Area of Science:

  • Pulmonary Medicine
  • Cardiovascular Research
  • Cell Biology

Background:

  • Cell injury in lung tissue is linked to chronic obstructive pulmonary disease (COPD) progression.
  • Endothelial injury in pulmonary capillaries contributes to lung destruction and cardiovascular disease, a leading cause of death in COPD patients.
  • Endothelial microparticles (EMPs) are emerging as potential biomarkers for COPD due to their association with endothelial injury.

Purpose of the Study:

  • To investigate the role of endothelial microparticles (EMPs) as potential biomarkers for chronic obstructive pulmonary disease (COPD).
  • To assess the correlation between specific EMP subtypes and the severity of lung destruction and airflow limitation in COPD patients.

Main Methods:

  • Analysis of eight distinct EMP subtypes defined by specific endothelial markers.
  • Comparison of EMP levels in stable COPD, exacerbated COPD, and non-COPD individuals.
  • Correlation analysis between EMP levels and clinical parameters such as lung destruction and airflow limitation.

Main Results:

  • Levels of vascular endothelial-cadherin, platelet endothelial cell adhesion molecule, and E-selectin EMPs are elevated in stable and exacerbated COPD patients compared to controls.
  • These specific EMP levels significantly correlate with lung destruction and airflow limitation in COPD patients.
  • Variations in the levels of different EMP subtypes were observed, suggesting complex pathophysiological roles.

Conclusions:

  • Endothelial injury is closely associated with the pathophysiology of COPD.
  • Specific EMP subtypes show promise as predictive biomarkers for COPD severity and progression.
  • Further research into the differential expression patterns of EMP subtypes may elucidate their clinical significance in COPD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30